Benzinga
Benzinga
Benzinga
dimanche, septembre 27

Guardian Pharmacy Services Inc

GRDNNYSE
Trade with Public
Trade with Public
$41.21
-0.58-1.39%
À la clôture: Sep 25, 5:00 PM EST
$41.21
N/A
Après les heures: Sep 25, 4:00 PM EST
AperçuActualitésPrévisions de résultatsÉvénementsObjectifs de coursDonnées financièresSentimentActionnariatComparerOptionsRapport sur les stocks

Guardian Pharmacy Service Analyst Price Targets

Wall Street analyst price targets and consensus rating for Guardian Pharmacy Service (GRDN).

Price Target Range — 7 Quarters

Analyst Consensus — 6 Analysts

6Buy
Consensus RatingBuy# Analysts6Avg. Consensus PT$43Upside to Avg. PT+4.0%

Rating Trend — Last 9 Months

Recent Analyst Actions

Voir toutes les évaluations →
DateFirmAnalystActionRating ChangePrice Target
Sep 23, 2026KeybancZach HaggertyInitiateOverweight$52
Sep 21, 2026Truist SecuritiesDavid MacdonaldPT RaiseBuy$47→$51
More with Benzinga EdgeGet Access

Analyst Ratings News

This HCA Healthcare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Analysts initiated bullish coverage on HCA, GRDN, TTC, MRVL and PLSE, setting price targets of $495, $52, $120, $270 and $70.
Avi Kapoor

PRO
Keybanc Initiates Coverage On Guardian Pharmacy Service with Overweight Rating, Announces Price Target of $52

Keybanc analyst Zach Haggerty initiates coverage on Guardian Pharmacy Service (NYSE:GRDN) with a Overweight rating and announces Price Target of $52.
Benzinga Newsdesk

PRO
Truist Securities Maintains Buy on Guardian Pharmacy Service, Raises Price Target to $51

Truist Securities analyst David Macdonald maintains Guardian Pharmacy Service (NYSE:GRDN) with a Buy and raises the price target from $47 to $51.
Benzinga Newsdesk

PRO
Oppenheimer Maintains Outperform on Guardian Pharmacy Service, Raises Price Target to $49

Oppenheimer analyst Michael Wiederhorn maintains Guardian Pharmacy Service (NYSE:GRDN) with a Outperform and raises the price target from $43 to $49.
Benzinga Newsdesk

PRO
Truist Securities Maintains Buy on Guardian Pharmacy Service, Raises Price Target to $47

Truist Securities analyst David Macdonald maintains Guardian Pharmacy Service (NYSE:GRDN) with a Buy and raises the price target from $43 to $47.
Benzinga Newsdesk

PRO
B of A Securities Maintains Buy on Guardian Pharmacy Service, Raises Price Target to $47

B of A Securities analyst Allen Lutz maintains Guardian Pharmacy Service (NYSE:GRDN) with a Buy and raises the price target from $42 to $47.
Benzinga Newsdesk

Données et API: API Benzinga · API d'actualités boursières · API de notations d'analystes · API de logo d'entreprise

Données de marché fournies par API Benzinga

Benzinga

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL

© 2026 Benzinga | All Rights Reserved